selinexor
Showing 51 - 75 of 101
Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)
Recruiting
- Multiple Myeloma
- +6 more
- Selinexor
- +3 more
-
Tucson, Arizona
- +9 more
Jan 5, 2022
Acute Myeloid Leukemia (Relapsed/Refractory) Trial in Frankfurt am Main, Hannover, Hamburg (Selinexor, Idarubicin, Cytarabine)
Completed
- Acute Myeloid Leukemia (Relapsed/Refractory)
- Selinexor
- +2 more
-
Frankfurt am Main, Hessen, Germany
- +2 more
Aug 1, 2021
Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers Trial in
Recruiting
- Advanced Refractory Solid Tumors
- +2 more
- Talazoparib
- Selinexor
-
Singapore, SingaporeNational University Hospital
Aug 31, 2021
Recurrent Melanoma Trial in Columbus (selinexor, Correlative studies)
Active, not recruiting
- Recurrent Melanoma
- selinexor
- Correlative studies
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Sep 5, 2022
Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)
Recruiting
- Glioblastoma Multiforme
- Selinexor
- +6 more
-
Birmingham, Alabama
- +17 more
Apr 1, 2022
Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)
Recruiting
- Myelofibrosis
- Selinexor
- Physician's Choice Treatment
-
Los Angeles, California
- +41 more
Jan 30, 2023
Peripheral T-cell Lymphoma Trial in Singapore (Selinexor, ICE Chemotherapy)
Completed
- Peripheral T-cell Lymphoma
- Selinexor
- ICE Chemotherapy
-
Singapore, SingaporeNational Cancer Centre Singapore
Apr 27, 2021
Multiple Myeloma Trial in Chengdu (Selinexor, Thalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Selinexor
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 13, 2021
Ovarian Cancer, Endometrial Cancer Trial in Middletown, Harrison, New York (Paclitaxel, Carboplatin, Selinexor)
Completed
- Ovarian Cancer
- Endometrial Cancer
- Paclitaxel
- +2 more
-
Middletown, New Jersey
- +2 more
Apr 22, 2021
Multiple Myeloma Trial in China (Selinexor, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +3 more
-
Changzhou, Jiangsu, China
- +5 more
Jun 11, 2023
Prostate Cancer Trial in Houston (Selinexor)
Terminated
- Prostate Cancer
- Selinexor
-
Houston, TexasM.D. Anderson Cancer Center
Jan 7, 2021
Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker
Completed
- Acute Myeloid Leukemia
- +4 more
- Laboratory Biomarker Analysis
- Selinexor
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 12, 2021
Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)
Recruiting
- Salivary Gland Cancer
- +3 more
- Selinexor
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 18, 2022
Advanced Malignant Solid Tumor, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8
Recruiting
- Advanced Malignant Solid Neoplasm
- +28 more
- Capecitabine
- +16 more
-
Conroe, Texas
- +4 more
Dec 5, 2022
Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)
Completed
- Dedifferentiated Liposarcoma
- Selinexor
- Placebo
-
Los Angeles, California
- +70 more
Jan 5, 2023
Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)
Coronavirus Infection Trial in Worldwide (Selinexor, Placebo)
Completed
- Coronavirus Infection
- Selinexor
- Placebo
-
Los Angeles, California
- +32 more
Oct 27, 2021
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Suzhou (Selinexor, Flu, CTX)
Recruiting
- Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Selinexor
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 3, 2022
Cancer, Covid19, Respiratory Viral Infection Trial in Melbourne (Interferon alfa, Selinexor, Lenzilumab)
Recruiting
- Cancer
- +2 more
- Interferon alfa
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Aug 11, 2021
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Refractory Multiple Myeloma Trial in Spain (Selinexor, Daratumumab, Bortezomib)
Recruiting
- Refractory Multiple Myeloma
- Selinexor
- +3 more
-
Badalona, Spain
- +14 more
Feb 3, 2021
Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)
Withdrawn
- Liposarcoma
- +4 more
- Selinexor
- Ixazomib
-
New York, New YorkColumbia University Medical Center
Nov 24, 2020
Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)
Completed
- Acute Myeloid Leukemia (AML)
- Selinexor
- +2 more
-
Los Angeles, California
- +77 more
Jan 24, 2023